Sanofi (SNY) Receivables Refunds (2016 - 2025)
Historic Receivables Refunds for Sanofi (SNY) over the last 11 years, with Q4 2025 value amounting to $462.2 million.
- Sanofi's Receivables Refunds fell 4026.25% to $462.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $462.2 million, marking a year-over-year decrease of 4026.25%. This contributed to the annual value of $448.7 million for FY2025, which is 4274.59% down from last year.
- Per Sanofi's latest filing, its Receivables Refunds stood at $462.2 million for Q4 2025, which was down 4026.25% from $581.0 million recorded in Q3 2025.
- Sanofi's Receivables Refunds' 5-year high stood at $773.7 million during Q4 2024, with a 5-year trough of $317.7 million in Q2 2024.
- For the 5-year period, Sanofi's Receivables Refunds averaged around $522.1 million, with its median value being $466.2 million (2025).
- Its Receivables Refunds has fluctuated over the past 5 years, first tumbled by 5139.09% in 2021, then surged by 8390.23% in 2024.
- Quarter analysis of 5 years shows Sanofi's Receivables Refunds stood at $700.1 million in 2021, then tumbled by 45.5% to $381.6 million in 2022, then increased by 10.25% to $420.7 million in 2023, then soared by 83.9% to $773.7 million in 2024, then crashed by 40.26% to $462.2 million in 2025.
- Its last three reported values are $462.2 million in Q4 2025, $581.0 million for Q3 2025, and $449.4 million during Q2 2025.